Dr. Sridevi  Chigurupati
My Social Links

Dr. Sridevi Chigurupati

Assistant Professor
Qassim University, Saudi Arabia


Highest Degree
Ph.D. in Pharmaceutical Sciences from Jawaharlal Nehru Technological University, Hyderabad, India

Share this Profile



Advertisement
Event

Area of Interest:

Biomedical Sciences
100%
Pharmacy
62%
Medicinal Chemistry
90%
Antioxidant Activities
75%
Pharmaceutical Chemistry
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Taha, M., T. Noreen, S. Imran, F. Nawaz and S. Chigurupati et al., 2019. Synthesis, α-amylase inhibition and molecular docking study of bisindolylmethane sulfonamide derivatives. Med. Chem. Res., 28: 2010-2022.
    CrossRef  |  Direct Link  |  
  2. Taha, M., M. Irshad, S. Imran, F. Rahim and M. Selvaraj et al., 2019. Thiazole based carbohydrazide derivatives as α-amylase inhibitor and their molecular docking study. Heteroatom Chem., Vol. 2019. 10.1155/2019/7502347.
    CrossRef  |  Direct Link  |  
  3. Salar, U., K.M. Khan, S. Chigurupati, S. Syed and S. Vijayabalan et al., 2019. New hybrid scaffolds based on hydrazinyl thiazole substituted coumarin; As novel leads of dual potential; In vitro α-amylase inhibitory and antioxidant (DPPH and ABTS radical scavenging) activities. Med. Chem., 15: 87-101.
    CrossRef  |  Direct Link  |  
  4. Rafique, R., K.M. Khan, S. Chigurupati, A. Wadood and A.U. Rehman et al., 2019. Synthesis of new indazole based dual inhibitors of α-glucosidase and α-amylase enzymes, their in vitro, in silico and kinetics studies. Bioorg. Chem., (In Press). 10.1016/j.bioorg.2019.103195.
    CrossRef  |  Direct Link  |  
  5. Karunanidhi, A., E. Ghaznavi-Rad, J.J. Nathan, N. Joseph and S. Chigurupati et al., 2019. Bioactive 2-(methyldithio) pyridine-3-carbonitrile from Persian shallot (Allium stipitatum Regel.) exerts broad-spectrum antimicrobial activity. Molecules, Vol. 24. 10.3390/molecules24061003.
    CrossRef  |  Direct Link  |  
  6. Hameed, S., F. Seraj, R. Rafique, S. Chigurupati and A. Wadood et al., 2019. Synthesis of benzotriazoles derivatives and their dual potential as α-amylase and α-glucosidase inhibitors in vitro: Structure-activity relationship, molecular docking and kinetic studies. Eur. J. Med. Chem., Vol. 183. 10.1016/j.ejmech.2019.111677.
    CrossRef  |  Direct Link  |  
  7. Chigurupati, S., V. Shantini, K.S. Kesavanarayanan, E.H. Nadia, M. Vasudevan, S.A. Eiman and D. Suprava, 2019. Identification of Nephelium lappaceum leaves phenolic and flavonoid component with radical scavenging, antidiabetic and antibacterial potential. Indian J. Tradit. Knowl., 18: 360-365.
    Direct Link  |  
  8. Chigurupati, S., S.N. Sitansu, K.Y. Dong, K.S. Kesavanarayanan, A.S. Sohrab, I.M. Jahidul and R.N. Appala, 2019. Inhibitory activities of α-glucosidase and α-amylase and their hypoglycaemic capability in the treatment of diabetes. EC Pharmacol. Toxicol., 7: 79-91.
  9. Chigurupati, S., S. Vijayabalan, K.K. Selvarajan, M. Aldubayan, A. Alhowail, V. Mani and S. Das, 2019. Antimicrobial exploration between counterpart endosymbiont and host plant (Tamarindus indica Linn.). Curr. Pharm. Biotechnol., (In Press). 10.2174/1389201020666191028105325.
    CrossRef  |  Direct Link  |  
  10. Yousuf, S., K.M. Khan, U. Salar, S. Chigurupati and M.T. Muhammad et al., 2018. 2’-Aryl and 4’-arylidene substituted pyrazolones: As potential α-amylase inhibitors. Eur. J. Med. Chem., 159: 47-58.
    CrossRef  |  Direct Link  |  
  11. Wang, D., C. Ozen, I.M. Abu-Reidah, S. Chigurupati and J.K. Patra et al., 2018. Vasculoprotective effects of pomegranate (Punica granatum L.). Front. Pharmacol., Vol. 9. 10.3389/fphar.2018.00544.
    CrossRef  |  Direct Link  |  
  12. Taha, M., M.S. Baharudin, N.H. Ismail, S. Imran and M.N. Khan et al., 2018. Synthesis, α-amylase inhibitory potential and molecular docking study of indole derivatives. Bioorg Chem., 80: 36-42.
    CrossRef  |  Direct Link  |  
  13. Khan, M., A. Alam, K.M. Khan, U. Salar and S. Chigurupati et al., 2018. Flurbiprofen derivatives as novel α-amylase inhibitors: Biology-oriented drug synthesis (BIODS), in vitro and in silico evaluation. Bioorg. Chem., 81: 157-167.
    CrossRef  |  Direct Link  |  
  14. Karunanidhi, A., E. Ghaznavi-Rad, R.A. Hamat, M.R. Pichika and L.T. Lung et al., 2018. Antibacterial and antibiofilm activities of nonpolar extracts of Allium stipitatum Regel. against multidrug resistant bacteria. BioMed Res. Int., Vol. 2018. 10.1155/2018/9845075.
    CrossRef  |  Direct Link  |  
  15. Chigurupati, S., M.R. Marri, S. Vijayabalan and Selvarajan, 2018. Bacterial endo-symbiont inhabiting Durio zibethinus leaves and their antibacterial potential. Int. J. PharmTech Res., 11: 198-205.
    CrossRef  |  Direct Link  |  
  16. Chigurupati, S., M. Selvaraj, V. Mani, J.I. Mohammad and K.K. Selvarajan et al., 2018. Synthesis of azomethines derived from cinnamaldehyde and vanillin: In vitro aetylcholinesterase inhibitory, antioxidant and insilico molecular docking studies. Med. Chem. Res., 27: 807-816.
    CrossRef  |  Direct Link  |  
  17. Chigurupati, S., E.W.K. Yiik, J.I. Mohammad, S. Vijayabalan, K.K. Selvarajan and S.S. Nanda, 2018. Screening antimicrobial potential for Malaysian originated Tamarindus indica ethanolic leaves extract. Asian J. Pharm. Clin. Res., 11: 361-363.
    CrossRef  |  Direct Link  |  
  18. Bale, A.T., K.M. Khan, U. Salar, S. Chigurupati and T. Fasina et al., 2018. Chalcones and bis-chalcones: As potential α-amylase inhibitors; synthesis, in vitro screening and molecular modelling studies. Bioorg. Chem., 79: 179-189.
    CrossRef  |  Direct Link  |  
  19. Al-Arifi, A.A., A. Kumar, S. Chigurupati, M. Jawed and T. Pandurangan, 2018. Pretreatment variations in haematological parameters of breast cancer patients. Int. J. Pharm. Pharm. Sci., 10: 157-161.
    CrossRef  |  Direct Link  |  
  20. Adegboye, A.A., K.M. Khan, U. Salar, S.A. Aboaba and S. Chigurupati et al., 2018. 2-Aryl benzimidazoles: Synthesis, in vitro α-amylase inhibitory activity and molecular docking study. Eur. J. Med. Chem., 150: 248-260.
    CrossRef  |  Direct Link  |  
  21. Taha, M., S.A.A. Shah, S. Imran, M. Afifi and S. Chigurupati et al., 2017. Synthesis and in vitro study of benzofuran hydrazone derivatives as novel alpha-amylase inhibitor. Bioorg. Chem., 75: 78-85.
    CrossRef  |  Direct Link  |  
  22. Taha, M., S. Imran, N.H. Ismail, M. Selvaraj and F. Rahim et al., 2017. Biology-oriented drug synthesis (BIODS) of 2-(2-methyl-5-nitro-1H-imidazol-1-yl) ethyl aryl ether derivatives, in vitro α-amylase inhibitory activity and in silico studies. Bioorg. Chem., 74: 1-9.
    CrossRef  |  Direct Link  |  
  23. Taha, M., M.T. Javid, S. Imran, M. Selvaraj and S. Chigurupati et al., 2017. Synthesis and study of the α-amylase inhibitory potential of thiadiazole quinoline derivatives. Bioorg. Chem., 74: 179-186.
    CrossRef  |  Direct Link  |  
  24. Taha, M., M. Irshad, S. Imran, S. Chigurupati anbd M. Selvaraj et al., 2017. Synthesis of piperazine sulfonamide analogs as diabetic-II inhibitors and their molecular docking study. Eur. J. Med. Chem., 141: 530-537.
    CrossRef  |  Direct Link  |  
  25. Salar, U., K.M. Khan, S. Chigurupati, M. Taha and A. Wadood et al., 2017. New hybrid hydrazinyl thiazole substituted chromones: As potential α-amylase inhibitors and radical (DPPH & ABTS) scavengers. Scient. Rep., Vol. 7. 10.1038/s41598-017-17261-w.
    CrossRef  |  Direct Link  |  
  26. Perumal, P., M. Vasudevan, C. Sridevi and M. Selvaraj, 2017. Anticholinesterase activity of octa peptides related to human histatin 8: In-silico drug design and in-vitro. Asian J. Pharm. Clin. Res., 10: 115-117.
    CrossRef  |  Direct Link  |  
  27. Noreen, T., M. Taha, S. Imran, S. Chigurupati and F. Rahim et al., 2017. Synthesis of alpha amylase inhibitors based on privileged indole scaffold. Bioorg. Chem., 72: 248-255.
    CrossRef  |  Direct Link  |  
  28. Mohammad, J.I., S. Chigurupati, O.A. Shahril and M.Z. Iqbal, 2017. Diabetic nephropathy an obvious complication in long term type-1 diabetes mellitus: A case study. Asian J. Pharm. Clin. Res., 10: 4-7.
  29. Mohammad, J.I., S. Chigurupati, M.K.A. Mallik and H. Noor, 2017. A case study on anion gap metabolic acidosis secondary to diabetes ketoacidosis. J. Innov. Pharm. Sci., 1: 58-59.
  30. Imran, S., M. Taha, M. Selvaraj, N.H. Ismail, S. Chigurupati and J.I. Mohammad, 2017. Synthesis and biological evaluation of indole derivatives as α-amylase inhibitor. Bioorg. Chem., 73: 121-127.
    CrossRef  |  Direct Link  |  
  31. Das, S., M.T. Thuwin, S. Deborah, G. Lubnashirin, M.S. Kabir and S. Chigurupati, 2017. A prospective clinicaltrial of amlodipine in comparison to perindopril. Int. J. Pharm. Pharm. Sci., 9: 268-270.
    CrossRef  |  Direct Link  |  
  32. Chigurupati, S., S.A. Shaikh, J.I. Mohammad, K.K. Selvarajan and A.R. Nemala et al., 2017. In vitro antioxidant and in vivo antidepressant activity of green synthesized azomethine derivatives of cinnamaldehyde. Indian J. Pharmacol., 49: 229-235.
    CrossRef  |  PubMed  |  Direct Link  |  
  33. Chigurupati, S., S. Muralidharan, L.S. Cin, W.Y. Raser, K. Santhi and K.S. Kesavanarayanan, 2017. Studying newly synthesized and developed 4-hydroxy-3-methoxybenzaldehyde schiff bases by UV spectrophotometry and high performance liquid chromatography. Pharm. Chem. J., 50: 789-794.
    CrossRef  |  Direct Link  |  
  34. Chigurupati, S., R.N. Appala, K.K. Selvarajan, C.H. Khaw, C.F. Teoh, L. Batumanathan and J.I. Mohammad, 2017.. LC method development and validation for the determination of ropivacaine hydrochloride in bulk drug and pharmaceutical formulations. Pharm. Chem. J., 51: 71-80.
    CrossRef  |  Direct Link  |  
  35. Chigurupati, S., J.I. Mohammad, S. Vijayabalan, N.D. Vaipuri, K.K. Selvarajan and A.R. Nemala, 2017. Quantitative estimation and antimicrobial potential of ethanol extract of Durio zibethinus Murr. leaves. Asian J. Pharm. Clin. Res., 10: 251-254.
  36. Chigurupati, S., N.K. Fuloria, S. Fuloria, S. Karupiah and R. Veerasamy et al., 2016. Synthesis and antibacterial profile of novel azomethine derivatives of β-phenylacrolein moiety. Trop. J. Pharm. Res., 15: 821-826.
    CrossRef  |  Direct Link  |  
  37. Chigurupati, S., M. Selvaraj, V. Mani, K.K. Selvarajan and J.I. Mohammad et al., 2016. Identification of novel acetylcholinesterase inhibitors: Indolopyrazoline derivatives and molecular docking studies. Bioorg. Chem., 67: 9-16.
    CrossRef  |  Direct Link  |  
  38. Chigurupati, S., 2016. Search for novel compounds as acrolein scavengers. AIMST Bull., 2: 10-10.
  39. Chigurupati, S., 2016. Xanthones scaffolds from nature (Garcinia). AIMST Bull., 2: 20-20.
  40. Bera, H. and S. Chigurupati, 2016. Recent discovery of non-nucleobase thymidine phosphorylase inhibitors targeting cancer. Eur. J. Med. Chem., 124: 992-1003.
    CrossRef  |  Direct Link  |  
  41. Appala, R.N., S. Chigurupati, R.V.V.S.S. Appala, K.K. Selvarajan and J.I. Mohammad, 2016. A simple HPLC-UV method for the determination of glutathione in PC-12 cells. Scientifica, Vol. 2016. 10.1155/2016/6897890.
    CrossRef  |  Direct Link  |  
  42. Veerasamy, R., S. Chigurupati, S. Sivadasan, D.S. Arumugam, H. Rajak and S.K. Krishnan, 2015. Exploring the relationship between the physico-chemical parameters and anti-tubercular activity of quinoline-3-carboxylic acids: A QSAR approach. Med. Chem. Res., 24: 744-752.
    CrossRef  |  Direct Link  |  
  43. Chigurupati, S., S.A. Dhanaraj and P. Balakumar, 2015. A step ahead of PPARγ full agonists to PPARγ partial agonists: Therapeutic perspectives in the management of diabetic insulin resistance. Eur. J. Pharmacol., 755: 50-57.
    CrossRef  |  Direct Link  |  
  44. Chigurupati, S., 2015. Designing new vanillin schiff bases and their antibacterial studies. J. Med. Bioeng., 4: 363-366.
  45. Sivadasan, S., A.N. Ali, K. Marimuthu, Z.A. Nazer, S. Chigurupati and R. Veerasamy, 2014. Menstrual disorders among students-An overview. Res. J. Pharm. Technol., 7: 704-711.
  46. Santhi, K., S.A. Dhanaraj, S. Chigurupati and S. Muralidharan, 2014. Therapeutic significance of polymeric nano particles as carriers for sustained ocular therapy: An overview. Res. J. Pharm. Biol. Chem. Sci., 5: 553-560.
  47. Chigurupati, S., R. Veerasamy, A.R. Nemala, A. Gowlikar and K.S. Lee, 2014. Designing and in-vitro antibacterial activity of new benzotriazole compounds. World J. Pharm. Pharm. Sci., 3: 1645-1651.
  48. Sridevi, C., M.M. Kannan and G. Abhinayani, 2013. Designing and biological evaluation of new benzimidazole compounds. Chem. Sci. Trans., 2: 922-926.
  49. Sridevi, C., K. Balaji and A. Naidu, 2011. Synthesis and pharmacological evaluation of some phenylpyrazolo indoquinoxaline derivatives. J. Chem., 8: 924-930.
    CrossRef  |  Direct Link  |  
  50. Sridevi, C., K. Balaji, A. Naidu and R. Sudhakaran, 2010. Synthesis of some phenylpyrazolo benzimidazolo quinoxaline derivatives as potent antimicrobial agents. J. Chem. Pharm. Sci., 3: 13-16.
  51. Sridevi, C., K. Balaji, A. Naidu and R. Sudhakaran, 2010. Synthesis of some phenylpyrazolo benzimidazolo quinoxaline derivatives as potent antihistaminic agents. J. Chem., 7: 234-238.
    CrossRef  |  Direct Link  |  
  52. Sridevi, C., K. Balaji, A. Naidu, S. Kavimani, D. Venkappayya, R. Suthakaran and S. Parimala, 2009. Synthesis of some phenylpyrazolo benzothiazolo quinoxaline derivatives. Int. J. PharmTech Res., 1: 816-821.
  53. Sridevi, C., K. Balaji, A. Naidu and R. Sudhakaran, 2009. Synthesis of some phenylpyrazolo benzimidazolo quinoxaline derivatives. Orient. J. Chem., 25: 325-328.
  54. Sridevi, C., K. Balaji, A. Naidu and R. Sudhakaran, 2009. Antioxidant, anti-inflammatory and histaminic activities of some phenyl pyrazolo benzothiazolo quinoxaline derivatives. J. Chem. Sci., 7: 1117-1126.
  55. Sridevi, C., K. Balaji, A. Naidu and R. Sudhakaran, 2009. Antioxidant and antiinflammatory activity of some phenylpyrazolo benzimidazolo quinoxaline derivatives. J. Pharm. Res., 2: 1500-1503.
  56. Sridevi, C., K. Balaji, A. Naidu and R. Sudhakaran, 2009. Antimicrobial evaluation and synthesis of some phenylpyrazolo benzothiazolo quinoxaline derivatives. J. Chem., 6: 866-870.
    CrossRef  |  Direct Link  |  
  57. Parimala, S., G. Shashidhar, C. Sridevi, V. Jyothi and R. Suthakaran, 2009. Anti-inflammatory activity of Celastrus paniculatus seeds. Int. J. Pharm. Technol. Res., 1: 1326-1329.
    Direct Link  |  
  58. Suthakaran, R., M.B. Raju, S. Kavimani, P. Venkappayya, R. Kumar and C.S.C.R.K. Suganthi, 2008. Synthesis, antioxidant, anti-inflammatory anti-microbial activity of 2-[(5-substituted aryl-1’n-substituted aryl amino methyl)pyrazol-3-yl] benzofuran. Rasayan J. Chem., 1: 39-45.
    Direct Link  |  
  59. Sridevi, C., K. Balaji, A. Naidu and R. Sudhakaran, 2008. Synthesis and biological evaluation of some indoquinoxaline pyrazolines. Rasayan J. Chem., 1: 306-314.
    Direct Link  |  
  60. Suthakaran, R., G. Somasekhar, C. Sridevi, M. Marikannan, K. Suganthi and G. Nagarajan, 2007. Synthesis, antiinflammatory, antioxidant and antibacterial activities of 7-methoxy benzofuran pyrazoline derivatives. Asian J. Chem., 19: 3353-3362.
  61. Jessy, E.M., A.T. Sambanthan, J. Alex, C.H. Sridevi and K.K. Srinivasan, 2007. Synthesis and biological evaluation of some novel quinazolones. Indian J. Pharm. Sci., 69: 476-478.
    CrossRef  |  Direct Link  |  
  62. Babu, V.H., C. Sridevi, A. Joseph and K.K. Srinivasan, 2007. Synthesis and biological evaluation of some novel pyrazolines. Indian J. Pharm. Sci., 69: 470-473.
    CrossRef  |  Direct Link  |